BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20888407)

  • 1. Fullerene antioxidants decrease organophosphate-induced acetylcholinesterase inhibition in vitro.
    Ehrich M; Van Tassell R; Li Y; Zhou Z; Kepley CL
    Toxicol In Vitro; 2011 Feb; 25(1):301-7. PubMed ID: 20888407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of carboxylesterases in SH-SY5Y human and NB41A3 mouse neuroblastoma cells by organophosphorus esters.
    Ehrich M; Correll L
    J Toxicol Environ Health A; 1998 Mar; 53(5):385-99. PubMed ID: 9515941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative non-cholinergic neurotoxic effects of paraoxon and diisopropyl fluorophosphate (DFP) on human neuroblastoma and astrocytoma cell lines.
    Qian Y; Venkatraj J; Barhoumi R; Pal R; Datta A; Wild JR; Tiffany-Castiglioni E
    Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):162-71. PubMed ID: 17223147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative kinetics of organophosphates and oximes with erythrocyte, muscle and brain acetylcholinesterase.
    Herkert NM; Freude G; Kunz U; Thiermann H; Worek F
    Toxicol Lett; 2012 Mar; 209(2):173-8. PubMed ID: 22230262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oximes on muscle force and acetylcholinesterase activity in isolated mouse hemidiaphragms exposed to paraoxon.
    Thiermann H; Eyer P; Worek F; Szinicz L
    Toxicology; 2005 Oct; 214(3):190-7. PubMed ID: 16040183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avian embryonic brain reaggregate culture system. II. NTE activity discriminates between effects of a single neuropathic or nonneuropathic organophosphorus compound exposure.
    Funk KA; Liu CH; Higgins RJ; Wilson BW
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):159-63. PubMed ID: 8291056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.
    Musilek K; Holas O; Kuca K; Jun D; Dohnal V; Opletalova V; Dolezal M
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3172-6. PubMed ID: 17383875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques.
    Bajgar J; Hajek P; Zdarova JK; Kassa J; Paseka A; Slizova D; Krs O; Kuca K; Jun D; Fusek J; Capek L
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):790-7. PubMed ID: 21054236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel oximes as blood-brain barrier penetrating cholinesterase reactivators.
    Garcia GE; Campbell AJ; Olson J; Moorad-Doctor D; Morthole VI
    Chem Biol Interact; 2010 Sep; 187(1-3):199-206. PubMed ID: 20227398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of organophosphorus hydrolysing enzymes on obidoxime-induced reactivation of organophosphate-inhibited human acetylcholinesterase.
    Herkenhoff S; Szinicz L; Rastogi VK; Cheng TC; DeFrank JJ; Worek F
    Arch Toxicol; 2004 Jun; 78(6):338-43. PubMed ID: 14985944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human fetal brain acetylcholinesterase: marker effect of neurotoxicity.
    Banerjee J; Ghosh P; Mitra S; Ghosh N; Bhattacharya S
    J Toxicol Environ Health; 1991 Jul; 33(3):283-90. PubMed ID: 1906943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of oxime-induced reactivation of erythrocyte and muscle AChE from different animal species following inhibition by sarin or paraoxon.
    Herkert NM; Aurbek N; Eyer P; Thiermann H; Worek F
    Toxicol Lett; 2010 May; 194(3):94-101. PubMed ID: 20156534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of five acetylcholinesterase reactivators on tabun-intoxicated rats: induction of oxidative stress versus reactivation efficacy.
    Pohanka M; Karasova JZ; Musilek K; Kuca K; Kassa J
    J Appl Toxicol; 2009 Aug; 29(6):483-8. PubMed ID: 19338015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone acetylase inhibitor trichostatin A induces acetylcholinesterase expression and protects against organophosphate exposure.
    Curtin BF; Tetz LM; Compton JR; Doctor BP; Gordon RK; Nambiar MP
    J Cell Biochem; 2005 Nov; 96(4):839-49. PubMed ID: 16149071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective bisquaternary reactivators of tabun-inhibited AChE.
    Kuca K; Cabal J; Musilek K; Jun D; Bajgar J
    J Appl Toxicol; 2005; 25(6):491-5. PubMed ID: 16092078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico pharmacophore model for tabun-inhibited acetylcholinesterase reactivators: a study of their stereoelectronic properties.
    Bhattacharjee AK; Kuca K; Musilek K; Gordon RK
    Chem Res Toxicol; 2010 Jan; 23(1):26-36. PubMed ID: 20028185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?
    Aurbek N; Herkert NM; Koller M; Thiermann H; Worek F
    Chem Biol Interact; 2010 Sep; 187(1-3):215-9. PubMed ID: 20105433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection from the toxicity of diisopropylfluorophosphate by adeno-associated virus expressing acetylcholinesterase.
    Li B; Duysen EG; Poluektova LY; Murrin LC; Lockridge O
    Toxicol Appl Pharmacol; 2006 Jul; 214(2):152-65. PubMed ID: 16443250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of acetylcholinesterase during adaptation to chronic, subacute paraoxon application in rat.
    Milatovic D; Dettbarn WD
    Toxicol Appl Pharmacol; 1996 Jan; 136(1):20-8. PubMed ID: 8560475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
    Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.